DOCSLIB.ORG

Organization Name Add1 Add2 Add3 City A. Menarini Diagnostics Ltd Wharfedale Road Winnersh Wokingham Berkshire A1 Pharmaceutical

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Organization Name Add1 Add2 Add3 City A. Menarini Diagnostics Ltd Wharfedale Road Winnersh Wokingham Berkshire A1 Pharmaceutical Organization Name Add1 Add2 Add3 City A. Menarini Diagnostics Ltd Wharfedale Road Winnersh Wokingham Berkshire A1 Pharmaceuticals Plc Units 3/4 Bessemer Park Ind.Est 250 Milkwood Road Herne Hill London AAF Bassington Lane Cramlington Northumbeland AAH Medical Unit 20 - Broombank Business Park Broombank Rd. Sheepbridge Chesterfield Derbyshire AAH Pharmaceuticals Ltd Walsgrave Triangle Walsgrave Coventry West Midlands Abbott Laboratories Limited Abbott House Norden Road Maidenhead Berks Aber Instruments Ltd Science Park Aberystwyth Aberystwyth Abertec Ltd The Old College Kings Street Aberystwyth Aberystwyth abtec Biologicals Ltd 396 Scotland Road Taylor Street I E Liverpool Merseyside Acambis PLC Peterhouse Technology Park 100 Fulbourn Road Cambridge Cambridgeshire Actinova Ltd 5 Signet Court Swanns Road Cambridge Cambs Adams Healthcare Ltd Lotherton Way Garforth Leeds Adaptive Biosystems Ltd 15 Ribocon Way Progress Business Park Luton Beds Adelphi (Tubes) Ltd Millgreen Road Haywards Heath West Sussex Advanced Biotechnologies Ltd Unit Units B1 & B2 Longmead Business Centre Blenheim Road Surrey Epsom Advanced Medical Solutions Group Plc Road Three Winsford Industrial Estate Windsford Cheshire Advanced Technologies (Cambridge) Ltd (ATC) 210 Cambridge Science Park Milton Road Cambridge Cambs Advante Holdings (UK) Ltd Plant Breeding Station Boothby Graffoe Lincs Aea Technology Biotechnology Services 353 Harwell Didcot Oxfordshire AEA Technology plc AEA Technology Biosciences F4 Culham Science Centre Abingdon Oxon AERES Biomedical Ltd 1-3 Burtonhole Lane Mill Hill London Aesculap Ltd Parkway Close Parkway Industrial Estate Sheffield AFFINITI Research Products Ltd Mamhead Castle Mamhead Exeter Devon Agrimin Ltd 11c The Flarepath Elsham World Industrial Estate Brigg S. Humberside AgriSense-BCS Ltd 1 Taffs Mead Road Treforest Industrial Estate Pontypridd Pontypridd Ahda Animal Health Distributor's Association Gable Court 8 Parsons Hill Hollesley Woodbridge Suffolk Ahpton Corp 125 Valley Road Chorleywood Hersts Air Products PLC Crockford Lane Chineham Basingstoke Hants Ajinomoto Pharma Europe Ltd Bridge Gate House 55 High Street Redhill Surrey Akita Pharmaceuticals Ltd 33 Moyle House Churchill Gdns Westminster London Alaris Medical Systems The Crescent Jays Close Basingstoke Hampshire Albachem Ltd Department of Chemistry King's Buildings West Mains Road Edinburgh Alcan Packaging Cramlington Ltd. 49 Colbourne Avenue Nelson Park Cramlington Northumberland Alchemy Laboratories Ltd Propect 2 Dundee Technology Park Dundee Scotland Organization Name Add1 Add2 Add3 City Lillyhall, Alco Waste Management Ltd Dixon House Joseph Nobel Road Workington Cumbria Alcon Laboratories Ltd Pentagon Park Boundary Way Hemel Hempstead Herts Alembic Products Ltd River Lane Saltney Chester Cheshire ALEXIS Corp (UK) Ltd 3 Moorbridge Court Moorbridge Road East Bingham Notts Alfa Biotech Ltd 4 Spring Lakes Estate Deadbrook Lane Aldershot Hants Alfa Laval Ltd, Separation Division 7 Doman Road Camberley Surrey Alizyme plc Granta Park Great Abington Cambridge Cambs Alk (Uk) 8 Bennet Rd Reading Berks Alkermes Europe Ltd The Quorum Barnwell Road Cambridge Allen & Hanburys Ltd Stockley Park West Uxbridge Middlesex Allen & Overy Legal Services One New Change London Allerayde 3 Sanigar Court Whittle Close Newark Notts Allergan Ltd Crown Centre Coronation Road High Wycombe Bucks Alliance Pharmaceuticals Ltd Avonbridge House 2 Bath Road Chippenham Wiltshire Allied Maintenance Serivces Ltd Providence Works Nield Street Oldham Lancs Alltech Applied Science Ltd Kellet Road Industrial Estate Carnforth Lancs Almedica Europe Ltd Unit 107, Tenth Avenue Deesude Ubdystruak Oarj Deeside Wales Alpha Environmental Systems Ltd 32-33 Loughanhill Industrial Estate Coleraine Coleraine N Ireland Alpha Laboratories Ltd 40 Parham Drive Eastleigh Hampshire Alpha TherapeuticUK Ltd Howlett Way Fison Way Industrial Estate Thetford Norfolk Alphamed Ltd Bensham House 324-340 Bensham Lane Thornton Heath Surrey Alpheus Environmental Ltd Cambridge Road Bedford Bedford Beds Alstoe Ltd Animal Health PO Box 5 Oakham Rutland Altana Pharma Ltd Three Globeside Business Park Field House Lane Marlow Bucks Amano Enzyme Europe Ltd Roundway House Cromwell Park Chippen Norton Oxfordshire AMEC PharmaChem Timothy's Bridge Road Stratford-upon-Avon Warwicks Warwicks St. Marys Way Amersham Health Sales and International Marketing Link House Chesham Buckinghamshire Amersham Pharmacia Biotech UK Ltd Amersham Place Little Chalfont Amersham Bucks Amersham Health - Amersham Amersham plc Biosciences Amersham Place Little Chalfont Buckinghamshire Amersham plc The Grove Centre White Lion Road Amersham Buckinghamshire Amersham plc The Maynard Centre Forest Farm Estate Whitchurch Cardiff Amersham plc Amersham Health Carolin Road Lower Tuffley Lane Gloucester Amersham plc Harwell Laboratories Building 10.23 Harwell Didcot Oxfordshire Organization Name Add1 Add2 Add3 City Amgen Ltd 240 Cambridge Science Park Milton Road Cambridge Cambs AMS Biotechnology (Europe) Ltd 185 A&B Milton Park Abingdon Oxon Oxford Science Amylin Europe Ltd John Eccles House Robert Robinson Ave Park Oxford Anachem Ltd Anachem Hourse 20 Charles Street Luton Beds Analox Instruments Ltd 8 Goldhawk Industrial Estate Brackenbury Road Hammersmith London Andard-Mount Co. Ltd West Africa House London Angiogene Pharmaceuticals Ltd 14 Plowden Park Aston Rowant Watlington Oxon Anglian Water Services Ltd (AWS) Anglian House Ambury Road Huntingdon Cambs Animal Health Trust PO Box 5 Newmarket Suffolk Animalcare Ltd Common Road Dunnington York Antec International Windham Road Chilton Industrial Estate Sudbury Suffolk Antigen Pharmaceuticals (Uk) Antigen House 82 Waterloo Road Hillside Southport Antisoma plc West Africa House Hanger Lane Ealing London Aplin and Barrett Ltd The Factory North Street Beaminster Dorset Applied biosystems Kelvin Close Birchwood Science Park North Warrington Cheshire Applied Enzyme Technology Ltd (AET) 175 Woodhouse Lane Leeds W Yorks Newcastle Upon Applied Imaging International Bioscience Centre Tynes Square Scotts Wood Road Tyne Approved Prescription Services Leeds Business Park 18 Bruntcliffe Way Morley Leeds Aps - Approved Prescription Services Ltd Hampden Park Brampton Road Eastbourne East Sussex APV Invensys 23 Gatwick Road Crawley W Sussex Aqua Systems (UK) Ltd Crossford Mill Johnstone Scotland Aqua-Med Ltd. 14 Boxhill Way Strood Green Betchworth Surrey Aquaculture Vaccines Ltd (AVL) Aquaculture House 24-26 Gold Street Saffron Walden Essex Aquagen Water Treatment Ltd The Corner House Ivychurch Romney Marsh Kent Arachnova St Johns Innovation Centre Cambridge Arc Pharmaceutical Ltd Kenyon Business Park Pilkington Street Bolton Ardern Healthcare Ltd Pipers Brook Farm Eastham Tenbury Wells Wocestershire ARM Ltd Rydal House Colton Road Rugeley Staffs Armour Pharmaceutical Co. Ltd RPR House 52 St. Leonards Rd Eastbourne East Sussex Arnolds Veterinary Products Cartmel Drive Harlescott Shrewsbury Shropshire Arrow Therapeutics Ltd Woodmasterne Road Carshalton Surrey Arrowmed Ltd Alderney House 58 Normandy Street Alton Hampshire Art Animal Reproductive Technologies Ltd Far View Shobdon Leominster Herts Organization Name Add1 Add2 Add3 City Arun PharmaceuticalsUK Ltd Delta House Southwood Crescent Southwood Hants Ashbourne Pharmaceuticals Victors Barnes Northampton Road Brixworth Northampton Ashfield Healthcare Ltd 42/48 Market Street Ashby de la Zouch Leicestershire Asta Medica 168 Cowley Road Cambridge Aston Molecules Ltd 10 Holt Court South Aston Science Park BirminghamUK Astra Tech Ltd Stroudwater Business Park Brunel Way Stonehouse Glos Astrazeneca Alderley House Alderley Park Macclesfield Cheshire Astrazeneca Bakewell Road Loughborough Leicestershire Emerging Markets Support & Silk Court. Silk Road Business AstraZeneca Development Organisation Park. Hulley Road Macclesfield Cheshire AstraZeneca 5300 Lakeside Cheadle Royal Business Park Cheshire AstraZeneca Corporate IS (Kings Court) Kings Court Water Lane Wilmslow Cheshire 5300 Lakeside Cheadle Royal AstraZeneca Corporate IS (Regus) Regus Business Park Cheadle Royal Cheshire AstraZeneca Corporate IS (Stuart House) Stuart House 50 Alderley Road Wilmslow Cheshire AstraZeneca Global Intellectual Property London Office 48 Curzon Street London Astrazeneca Limited Horizon Place 600 Capability Green Luton Bedfordshire Astrazeneca Plc 15 Stanhope Gate London AstraZeneca R&D Alderley Park Alderley Park Macclesfield Cheshire AstraZeneca Risk & Insurance Services 15 Stanhope Gate London AstraZeneca Trade Marks Group PO Box 141 Mereside Alderley Park Cheshire AstraZeneca UK - Clinical Research Group 10 Logie Mill Logie Green Road Edinburgh AstraZeneca UK Limited Brixham Environmental Laboratory Freshwater Quarry Brixham Devon AstraZeneca UK Manufacturing Hurdsfield Industrial Estate Macclesfield Cheshire Aululine Ltd Cedar House 16 Beaconsfield Street Blyth Northumberland Aurum Pharmaceuticals Ltd 48-50 High St Billingshurst West Sussex Aventis Behring Ltd Aventis House Markey Place Haywards Heath West Sussex Aventis Pasteur Msd Mallards Reach Bridge Avenue Maidenhead Berks Aventis Pharma Ltd RPR House 50 King Hill Avenue Kings Hill West Malling Avl Aquaculture Vaccines Ltd 24-26 Gold St Saffron Walden Essex Avlon Works Severn Road Hallen Bristol Bristol Organization Name Add1 Add2 Add3 City Axess Ltd John Busch House 277 London Road Isleworth Middx B Braun Medical Ltd Thorncliffe Park Sheffield B DUK Ltd Between Towns Road Cowley Oxford Babraham Bioscience Babraham Hall Babraham Cambridge Cambs
Load more

Recommended publications
  • Chief Executive Officer Graham Baker
    OVERVIEW OUR BUSINESS OPERATIONAL FINANCIAL RISK GOVERNANCE ACCOUNTS 48 & MARKETPLACE REVIEW REVIEW OUR BOARD OF DIRECTORS ROBERTO QUARTA (67) OLIVIER BOHUON (58) GRAHAM BAKER (48) CHAIRMAN CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER Joined the Board in December 2013 and Joined the Board and was appointed Chief -RLQLQJWKH%RDUGDV&KLHI)LQDQFLDO2I²FHULQ appointed Chairman following election by ([HFXWLYH2I²FHULQ$SULO+HUHVLJQHGDV March 2017. shareholders at the April 2014 Annual General a Member of the Nomination & Governance Meeting. He was also appointed Chairman of &RPPLWWHHRQ)HEUXDU\ CAREER AND EXPERIENCE the Nomination & Governance Committee and Graham holds an MA degree in Economics from a Member of the Remuneration Committee on CAREER AND EXPERIENCE Cambridge University and qualified as a Chartered that day. Olivier holds a doctorate in Pharmacy from the Accountant and Chartered Tax Advisor with Arthur University of Paris and an MBA from HEC, Paris. Andersen. In 1995, he joined AstraZeneca PLC where CAREER AND EXPERIENCE He started his career in Morocco with Roussel Uclaf he worked for 20 years, holding multiple senior roles, Roberto is a graduate and a former Trustee of the S.A. and then, with the same company, held a number including Vice President, Finance, International (2013- College of the Holy Cross, Worcester (MA), US. of positions in the Middle East with increasing levels of 2015) with responsibility for all emerging markets, He started his career as a manager trainee at David responsibility. He joined Abbott in Chicago as head of Vice President, Global Financial Services (2011-2013) Gessner Ltd, before moving on to Worcester Controls their anti-infective franchise with Abbott International and Vice President Finance & Chief Financial Officer, Corporation and then BTR plc, where he was a before becoming Pharmaceutical General Manager North America (2008-10).
    [Show full text]
  • Alderley Park the Future As a World-Class Life Science Facility Planning Application Summary Document
    DECEMBER 2015 ALDERLEY PARK THE FUTURE AS A WORLD-CLASS LIFE SCIENCE FACILITY PLANNING APPLICATION SUMMARY DOCUMENT Alderley Park is a world-class Life Science research and development (R&D) facility. The site currently houses around 190,000 sq m of premier scientific laboratory space, offices, restaurants, cafes, conferencing space and energy plant, set in 400 acres of parkland. As a centre for scientific research, it is one of the few facilities in the country with a comprehensive offering to support drug discovery and development. It was AstraZeneca’s global lead centre for cancer research, employing at its peak up to 10,000 people in highly skilled jobs. These facilities at Alderley Park are high-quality A planning application has been submitted to and high-tech, and require significant ongoing Cheshire East Council for future development investment to retain them. £550 million has been at Alderley Park. The planning application invested in Alderley Park since 1997 and further, has been allocated the reference number major investment is required to repurpose the site 15/5401M. from single to multi-occupier use, maintain the facilities and cover ongoing overheads. This summary document sets out the key elements of the proposals. ILLUSTRATIVE MASTERPLAN SIGNIFICANT INVESTMENT PROPOSED OVER THE NEXT 10 YEARS In March 2013, AstraZeneca announced The site was purchased by Bruntwood/MSP, its decision to relocate its R&D facilities to part of Alderley Park Ltd who now wish to Cambridge, leading to uncertainty over the secure the future of the site, retaining talent and future of Alderley Park and its role in the local jobs, by taking forward the Taskforce’s vision.
    [Show full text]
  • Novel Neutralizing Hedgehog Antibody MEDI-5304 Exhibits Antitumor Activity by Inhibiting
    Author Manuscript Published OnlineFirst on December 16, 2013; DOI: 10.1158/1535-7163.MCT-13-0420 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Fully Human Anti-Hedgehog Antibodies Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling. Authors: Neil R. Michaud1*, Youzhen Wang1, Kristen McEachern1, Jerold J. Jordan1, Anne Marie Mazzola1, Axel Hernandez1, Sanjoo Jalla2, Jon W. Chesebrough2, Mark J. Hynes3, Matthew Belmonte 1, Lidong Wang3, Jaspal S. Kang4#, Jelena Jovanović5, Naomi Laing1, David W. Jenkins1, Elaine Hurt2, Meina Liang6, Christopher Frantz7, Robert E. Hollingsworth2, Diane M. Simeone3, David C. Blakey8, and Vahe Bedian1* Authors’ affiliation: 1Oncology iMED, AstraZeneca-R&D Boston, Waltham, MA 2Oncology Research, MedImmune LLC, Gaithersburg, MD 3Translational Oncology Program, University of Michigan, Ann Arbor, MI; 4Amgen British Columbia, Burnaby, BC, Canada 5Lead Generation- Research, Medimmune LLC, Granta Park, Cambridge, UK 6Clinical Pharmacology and DMPK, MedImmune LLC, Hayward, CA 7Biologics Safety Assessment, MedImmune LLC, Mountain View, CA 8Oncology iMed, AstraZeneca, Alderley Park, Macclesfield. UK #Current address: Paul Kang, CSO, Innovative Targeting Solutions Inc., Burnaby BC, Canada *corresponding authors: Neil R. Michaud, Ph.D. Oncology iMED AstraZeneca-R&D Boston Waltham, MA 02451 e-mail: [email protected] Vahe Bedian Ph.D. Oncology iMED AstraZeneca-R&D Boston Waltham, MA 02451 phone:781-839-4613 e-mail: [email protected] Running title: Fully Human Anti-Hedgehog Antibodies Key Words: Hedgehog, Antibody, Xenograft, XenoMouse, cancer stem cells Grant Support: This work was funded by AstraZeneca PLC and MedImmune LLC. Disclosure of Potential Conflicts of Interest: There are no potential conflicts of interest.
    [Show full text]
  • Register of GDP Sites 2019
    Register of GDP Sites 2019 Updated 16 August 2019 There are other sites authorised for wholesale dealing of veterinary medicinal products which do not appear on this register. These sites wholesale deal in both human and veterinary medicinal products and can be found on the MHRA section of GOV.UK: https://www.gov.uk/government/publications/human-and-vetinary-medicines- register-of-licensed-wholesale-distribution-sites-december-2014 Register of Authorised Wholesale Dealer Sites Authorisation Holder: WDA33618 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0415 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0010 ABBEYVET LLP SHERBURN ENTERPRISE PARK, SHERBURN IN ELMET, LEEDS, WEST YORKSHIRE, LS25 6NB Authorisation Holder: WDA8599 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN SITE ID: S0015 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN Authorisation Holder: WDA5097 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0456 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0525 CVS GROUP PLC CVS HOUSE, OWEN ROAD, DISS, NORFOLK, IP22 4ER Authorisation Holder: WDA5030 ALBERT E JAMES & SON LIMITED BARROW MILL BARROW STREET, BARROW GURNEY, BRISTOL, BS48 3RU SITE ID: S0303 ALBERT E JAMES &
    [Show full text]
  • United States Securities and Exchange Commission Form 10-K Shire Pharmaceuticals Group
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1999 អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) N.A. East Anton, Andover, Hampshire SP10 5RG England (Address of principal executive offices) (Zip Code) 44 1264 333455 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depository Shares, each representing Nasdaq National Market 3 Ordinary Shares, 5 pence nominal value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ፤ No អ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant's knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • Listing of Global Companies with Ongoing Government Activity
    COMPANY LINE OF BUSINESS TICKER A & A BIOTECHNOLOGY S C ADAM BURKIEWICZ MIKOLAJ BURKIEWICZ PHARMACEUTICAL PREPARATIONS A & A GLOBAL INDUSTRIES, INC. AUTOMATIC VENDING MACHINES, NSK A & J ENTERPRISES PHARMACEUTICAL PREPARATIONS A & S INTERNATIONAL 2000 S.R.L. PHARMACEUTICAL PREPARATIONS A & S PHARMACEUTICAL CORP. PHARMACEUTICAL PREPARATIONS A & T MARKETING INC. COMPUTER INTEGRATED SYSTEMS DESIGN, NSK A & T SYSTEMS, INC. TELEPHONE COMMUNICATION, EXCEPT RADIO A & Z PHARMACEUTICAL INC. PHARMACEUTICAL PREPARATIONS A A INTERNATIONAL PHARMACEUTICAL PREPARATIONS A AND V, INC. BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC A AROGYA HARBALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A B ENTERPRISES PHARMACEUTICAL PREPARATIONS A B I HERBAL PRODUCTS MEDICINALS AND BOTANICALS, NSK A B S REMEDIES PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A BEAT FOR YOUR FEET, INC. COIN-OPERATED LAUNDRIES AND CLEANING, NSK A BUCKHEAD BUS COMPANY LOCAL PASSENGER TRANSPORTATION, NEC A C C VIEIRA PROTESE ME MEDICINALS AND BOTANICALS, NSK A C CONSULTING PHARMACEUTICAL PREPARATIONS A C E DIAGNOSTICS & BIOTECH LIMITED PHARMACEUTICAL PREPARATIONS A C E PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A C PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A CUT ABOVE LANDSCAPE LAWN AND GARDEN SERVICES A D C O MARKETING INC NONDURABLE GOODS, NEC, NSK A G HERBALS PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A G PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A H C PHARMACAL, INC PHARMACEUTICAL PREPARATIONS A H SYSTEMS INC INSTRUMENTS TO MEASURE ELECTRICITY A HOUSE OF AYURVEDIC
    [Show full text]
  • CRR 446/2002 a Study of the Provision of Health and Safety Information in the Annual Reports of the Top UK Companies
    HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Prepared by System Concepts Ltd for the Health and Safety Executive CONTRACT RESEARCH REPORT 446/2002 HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Laura Peebles, Ansgar Kupper and Tanya Heasman System Concepts Ltd 2 Savoy Court Strand London WC2R 0EZ This report details the findings of a research project to investigate the quality and quantity of health and safety information found in the annual reports of the top UK companies. At present, publicly listed companies are not legally required to include health and safety matters in their annual reports. The current Health and Safety Commission (HSC) Strategy Statement, however, contains an action point which focuses on public reporting of health and safety issues by larger companies. The aim is to promote the reporting of health and safety information in company annual reports and to provide guidance that would allow reporting of such information to a common standard. To assist the HSC with this strategy, System Concepts were commissioned by the Health and Safety Executive (HSE) to undertake an investigation of the provision of health and safety information in company annual reports. The study comprised a series of steps. The main objectives of the study were: i) To determine the current level of reporting of health and safety issues in annual reports of the top UK companies ii) To determine the quality of health and safety information reported.
    [Show full text]
  • Rape Research
    Rape Research After scene 2, in Paulson‘s Tavern, Tara is left behind whilst it empties out. This is the perfect setting for Danni to tranquilise her with a date rape drug. This is quite a strong subject, and I felt like the whole group should put more research and get a greater understanding, so we know how to deal with the situation and portray it through our performance. Personally, I have never known anyone who has experienced this situation before, so to ensure that I would create a believable performance and reaction, I needed to get a greater understanding and look at interviews, dramas and information about date rape and the affect it has on people‘s lives. BBC Health – Rohypnol http://www.bbc.co.uk/health/physical_health/conditions/rohypnol.shtml What is Rohypnol? Rohypnol is the brand name of a medicine called flunitrazepam, and is one of the benzodiazepine class of sedative or tranquilizer drugs, of which ‗Valium‘ or diazepam is perhaps the best known. Rohypnol or flunitrazepam is 10 times more potent than diazepam. In the UK the drug is no longer used in the NHS but may be available on private prescription for those who need it (although it‘s generally felt that there are better alternatives). Its legal status in the UK is a class C drug, which means that it‘s illegal to possess flunitrazepam without a prescription. It‘s not legally available in the US, but as it is still made in some countries an illegal trade continues. Rohypnol rose to prominence as the date rape drug because it was colourless, odourless, tasteless and easily dissolved - ideal for spiking drinks undetected - and causes sedation or euphoria in approximately 20 to 30 minutes.
    [Show full text]
  • Cold Chain Distribution Conference and Exhibition Enhance Temperature Management for an Efficient Supply Chain
    SMi PRESENTS THE 9TH ANNUAL COLD CHAIN DISTRIBUTION CONFERENCE AND EXHIBITION ENHANCE TEMPERATURE MANAGEMENT FOR AN EFFICIENT SUPPLY CHAIN 2ND - 3RD DECEMBER 2014 | MARRIOTT REGENTS PARK, LONDON UK Sponsorship Manual www.coldchain-distribution.com “ A very well organised event. Professional team and well executed” Cold Chain Delegate 2013 9th annual Cold Chain Distribution Conference and Exhibition Drawing on 8 years of working within the Cold Chain Logistics industry, the SMi Group are delighted to announce their 9th annual Cold Chain Distribution Conference and Exhibition. Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. Benefits of Attending: ● Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate ● Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo ● Strengthen your supply chain through management and efficiency insights from Merck Serono and Genzyme ● In addition, Cold Chain Distribution
    [Show full text]
  • 1999 Annual Report and Form 20-F CONTENTS
    1999 Annual Report and Form 20-F CONTENTS Key Achievements in 1999 1 Financial Highlights 2 Shareholder Highlights 5 Chairman’s Statement 6 Chief Executive’s Review 7 Operational Review 8 Safety, Health and Environment 32 In April 1999, Astra AB and Zeneca Group PLC People and Community 34 merged to form AstraZeneca, one of the world’s Financial Review 35 leading pharmaceutical and agrochemical Board of Directors and Officers companies, which provides innovative, effective of the Company 48 products to improve health, nutrition and quality Directors’ Report 49 of life worldwide. The company is research and Financial Statements 55 technology intensive, with extensive international Financial statements and notes development and marketing skills. Its healthcare relating to the financial statements 55 business is strategically focused on seven major Principal subsidiaries, joint ventures therapeutic areas: gastrointestinal, oncology, pain and associates 118 control and anaesthesia, cardiovascular, central Additional information for US investors 120 nervous system, respiratory and infection. Zeneca Group Financial Record 129 Agrochemicals provides crop protection products Shareholder Information 131 designed to improve crop yields and food quality. Exchange rates 138 Definitions 139 Glossary of Terms 140 Cross Reference to Form 20-F IBC Cautionary statement regarding forward-looking statements In order to utilise the ‘Safe Harbor’ provisions of the United States Private Securities Litigation Reform Act of 1995, AstraZeneca is providing the following cautionary statement. This Annual Report and Form 20-F 1999 contains forward-looking statements with respect to the financial condition, results of operations and businesses of AstraZeneca. By their nature, forward-looking statements and forecasts involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future.
    [Show full text]
  • SHIRE PHARMACEUTICALS GROUP PLC (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales 98-0359573 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Hampshire International Business Park, Chineham, +44 1256 894 000 Basingstoke, Hampshire, England, RG24 8EP (Registrant’s telephone number, including area code) (Address of principal executive offices and zip code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depositary Shares, each representing 3 NASDAQ National Market Ordinary Shares 5 pence par value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • 6Th Annual Translational Medicine Conference City Hotel, Derry/Londonderry, Northern Ireland 25Th - 26Th Sept 2014
    6th Annual Translational Medicine Conference ‘Personalising Health and Care’ Date: 25th and 26th September 2014 | Venue: City Hotel, Derry/Londonderry, N.Ireland, UK 1 6th Annual Translational Medicine Conference City Hotel, Derry/Londonderry, Northern Ireland 25th - 26th Sept 2014 Conference Sponsors 2 6th Annual Translational Medicine Conference City Hotel, Derry/Londonderry, Northern Ireland 25th - 26th Sept 2014 Contents Page Conference Programme .................................................................................... 4 Biographies .......................................................................................................... 6 - 9 Delegate List ........................................................................................................ 10 - 12 Bio-Entrepreneur Programme........................................................................ 13 About C-TRIC ....................................................................................................... 14 - 15 Abstracts Poster Presentations................................................................. 16 - 42 Abstracts Oral Presentations................................................................. 43 Abstracts Poster List................................................................. 44 3 6th Annual Translational Medicine Conference City Hotel, Derry/Londonderry, Northern Ireland 25th - 26th Sept 2014 ‘Personalising Health and Care’ - Conference Programme Day One Thursday 25th Sept 1:00 pm Registration and Tea/Coffee 4.30 pm Oral
    [Show full text]